Invitae (NYSE: NVTA) is a leading genetic testing and diagnostics company that offers a wide range of comprehensive genetic tests. They aggregate the world’s medical genetic tests into a single service with higher quality, faster turnaround times, and lower prices making it affordable and accessible to everyone who can benefit.

Their platform sets the standard for the medical genetics industry by harnessing the power of advanced technologies – robotics, artificial intelligence, machine learning, software engineering – and world-class genetic expertise.